Find a Tender
active
Official procurement procedure
Storage, Distribution and Labelling of Drugs for Clinical Trials
Pharmaceutical products
Published value
£250,000
Submission deadline 8 Apr 2024, 10:00 BST
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University of Leeds: "Storage, Distribution and Labelling of Drugs for Clinical Trials". Published status: active. Published value: £250,000. 3 published lots. Recorded submission deadline: 8 Apr 2024, 10:00 BST. See the official notice for participation instructions.
| Contracting Authority | University of Leeds | Scope & Categories | Not published | Submission Window | Closed 8 Apr 2024, 10:00 BST |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | £250,000 |
Bidder Intelligence · Authority Profile: University of Leeds
Market Analytics
Derived from OCDS awards & bid statistics
Published history for University of Leeds. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity of Leeds | Procedure methodNot published | Procurement categoryNot published |
Statusactive | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published26 Feb 2024, 16:05 GMT | Last source update26 Feb 2024, 16:05 GMT | Recurring procurementNo |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-043cee | ||
What is being bought
The Leeds Institute of Clinical Research at the University of Leeds (UoL) is seeking tenders for a supplier for the Storage, Distribution and Labelling of Drugs for Clinical Trials
This tender is made up of 3 Lots for 3 different trials
What changed
From the official release history
- Published value updated to £250,000
26 Feb 2024, 16:05 GMT - Status changed to active
26 Feb 2024, 16:05 GMT - Official notice release published
26 Feb 2024, 16:05 GMT - Submission deadline changed to 8 Apr 2024, 10:00 BST
26 Feb 2024, 16:05 GMT - Buyer information updated
26 Feb 2024, 16:05 GMT
Lots and requirements (3)
Published by the contracting authority
- Lot 1 · #1Lot 1 (Trial 1) – SPECTRUMactivePublished value£50,000This trial is subject is currently awaiting a funding award based on the funding application. The outcome of this tender will be part of the final application as we are required to demonstrate that we have sought to provide the best value for money to the funding body. The estimated start date for this trial is Q1 2025.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Lot 2 (Trial 2) – IMMERSEactivePublished value£200,000The estimated start date for this trial is Dec 2024. It is anticipated that 30 patients will be recruited to this trial over a period of 12 months (depending on patient recruitment rates) and patients will remain on treatment for a maximum of 36 months.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Lot 3 (Trial 3) – BITTENactivePublished value£200,000This trial is subject is currently awaiting a funding award based on the funding application. The outcome of this tender will be part of the final application as we are required to demonstrate that we have sought to provide the best value for money to the funding body. The estimated start date for this trial is Summer 2025. It is anticipated that 40 patients will be recruited to this trial over a period of 18 months (depending on patient recruitment rates) and patients will remain on treatment for a maximum of 12 months.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
26 Feb 2024, 16:05 GMT - Submission deadline
8 Apr 2024, 10:00 BST
Commercial outcome and competition
AwardsNo award published |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
University of Leeds
Contracting authority GB-FTS-105031Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published